The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Webcast
In this short webcast, Dena Jackson and Sophie Rutherford discuss connecting the organization to the supply chain department to build collabor
Case Studies
AHRMM is building a repository for leading and proven supply chain practices, case studies, and toolkits that are developed from a
Webcast
Lisa Fohey, director of supply chain, Children’s Hospital of Wisconsin, leads an overview of the main principals of project management and change
Webcast
Lisa Fohey, director of supply chain, Children’s Hospital of Wisconsin, explores the principles of project management and change management t
White Papers
In an effort to capture broader insights on UDI adoption from across the health care field, AHRMM, with participation by the FDA, held LUC Dat
Webcast
Explore the new delivery methods of health care, how community resources and organizations are now working together to reduce patient episodic